Search research articles
Contact Us
Filters
Showing results (171-180 of 316) with videos related to
Page
of 32
Sort By:
The EMBO Journal
|
July 12, 2001
Synthesis of a novel hepatitis C virus protein by ribosomal frameshift
Z Xu, J Choi, T S Yen, et al.
Lancet (London, England)
|
November 26, 1977
Maintenance of remission in acute myelogenous leukaemia by a mixture of B.C.G. and irradiated leukaemia cells
R L Powles, J A Russell, P J Selby, et al.
British Journal of Cancer
|
January 1, 1997
A phase II study of recombinant interferon-beta (r-hIFN-beta 1a) in combination with 5-fluorouracil (5-FU) in the treatment of patients with advanced colorectal carcinoma
J K Joffe, T J Perren, C Bradley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2011
Impact of patient-reported outcomes in oncology: a longitudinal analysis of patient-physician communication
Elena E Takeuchi, Ada Keding, Noha Awad, et al.
Journal of Cell Science
|
April 1, 2004
Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme
Claire L Varley, Jens Stahlschmidt, Wen-Chun Lee, et al.
Plos One
|
June 6, 2012
Tumour cell generation of inducible regulatory T-cells in multiple myeloma is contact-dependent and antigen-presenting cell-independent
Sylvia Feyler, Gina B Scott, Christopher Parrish, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1997
The use of fluorescent in situ hybridization for detection of the t(2;5)(p23;q35) translocation in anaplastic large-cell lymphoma
P W Johnson, J Leek, K Swinbank, et al.
British Journal of Haematology
|
February 1, 1989
In vitro studies of ways to overcome resistance to VAMP--high dose melphalan in the treatment of multiple myeloma
B C Millar, J B Bell, J A Maitland, et al.
Lancet (London, England)
|
November 30, 2000
Proteomics: new perspectives, new biomedical opportunities
R E Banks, M J Dunn, D F Hochstrasser, et al.
Proteomics
|
January 28, 2003
Serological and proteomic evaluation of antibody responses in the identification of tumor antigens in renal cell carcinoma
Richard D Unwin, Patricia Harnden, Darryl Pappin, et al.
Page
of 32
Search research articles
Search
Showing results (171-180 of 316) with videos related to
Sort By:
Page
of 32
The EMBO Journal
|
July 12, 2001
Synthesis of a novel hepatitis C virus protein by ribosomal frameshift
Z Xu, J Choi, T S Yen, et al.
Lancet (London, England)
|
November 26, 1977
Maintenance of remission in acute myelogenous leukaemia by a mixture of B.C.G. and irradiated leukaemia cells
R L Powles, J A Russell, P J Selby, et al.
British Journal of Cancer
|
January 1, 1997
A phase II study of recombinant interferon-beta (r-hIFN-beta 1a) in combination with 5-fluorouracil (5-FU) in the treatment of patients with advanced colorectal carcinoma
J K Joffe, T J Perren, C Bradley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2011
Impact of patient-reported outcomes in oncology: a longitudinal analysis of patient-physician communication
Elena E Takeuchi, Ada Keding, Noha Awad, et al.
Journal of Cell Science
|
April 1, 2004
Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme
Claire L Varley, Jens Stahlschmidt, Wen-Chun Lee, et al.
Plos One
|
June 6, 2012
Tumour cell generation of inducible regulatory T-cells in multiple myeloma is contact-dependent and antigen-presenting cell-independent
Sylvia Feyler, Gina B Scott, Christopher Parrish, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1997
The use of fluorescent in situ hybridization for detection of the t(2;5)(p23;q35) translocation in anaplastic large-cell lymphoma
P W Johnson, J Leek, K Swinbank, et al.
British Journal of Haematology
|
February 1, 1989
In vitro studies of ways to overcome resistance to VAMP--high dose melphalan in the treatment of multiple myeloma
B C Millar, J B Bell, J A Maitland, et al.
Lancet (London, England)
|
November 30, 2000
Proteomics: new perspectives, new biomedical opportunities
R E Banks, M J Dunn, D F Hochstrasser, et al.
Proteomics
|
January 28, 2003
Serological and proteomic evaluation of antibody responses in the identification of tumor antigens in renal cell carcinoma
Richard D Unwin, Patricia Harnden, Darryl Pappin, et al.
Page
of 32